Antisense above resistanceI've been watching rather than buying but this long shot has been showing signs of heating up recently. I might regret that. Two days of double-digit advances.
Next report date
Report period
H2 2024
EPS estimate
0.00USD
Revenue estimate
—
−0.0107USD
−7.58 MUSD
775.72 M
About PERCHERON THERAPEUTICS LIMITED
Sector
CEO
James Stuart Garner
Headquarters
Melbourne
Website
Founded
2000
ISIN
AU0000317281
FIGI
BBG000P1ZHL0
Percheron Therapeutics Ltd. engages in the research and development of novel antisense pharmacceuticals. It operates through the ATL1102, and ATL1103 segments. The ATL1102 segment represents the second generation antisense inhibitor of CD49d, the alpha subunit of very late antigen-four. The ATL1103 segment refers to atesidorsen is an antisense drug designed to block growth hormone receptor expression thereby reducing levels of the hormone insulin. The company was founded on November 13, 2000 and is headquartered in Toorak, Australia.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of ATHJF is 0.0100 USD — it has decreased by 80.00% in the past 24 hours. Watch PERCHERON THERAPEUTICS LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange PERCHERON THERAPEUTICS LTD stocks are traded under the ticker ATHJF.
PERCHERON THERAPEUTICS LTD is going to release the next earnings report on Aug 28, 2024. Keep track of upcoming events with our Earnings Calendar.
ATHJF stock is 400.00% volatile and has beta coefficient of −0.20. Track PERCHERON THERAPEUTICS LTD stock price on the chart and check out the list of the most volatile stocks — is PERCHERON THERAPEUTICS LTD there?
ATHJF earnings for the last quarter are −0.01 USD per share, whereas the estimation was −0.01 USD resulting in a 28.18% surprise. The estimated earnings for the next quarter are −0.01 USD per share. See more details about PERCHERON THERAPEUTICS LTD earnings.
Yes, you can track PERCHERON THERAPEUTICS LTD financials in yearly and quarterly reports right on TradingView.
ATHJF net income for the last quarter is −3.23 M USD, while the quarter before that showed −4.07 M USD of net income which accounts for 20.60% change. Track more PERCHERON THERAPEUTICS LTD financial stats to get the full picture.
Today PERCHERON THERAPEUTICS LTD has the market capitalization of 45.57 M, it has increased by 6.07% over the last week.
No, ATHJF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ATHJF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PERCHERON THERAPEUTICS LTD stock right from TradingView charts — choose your broker and connect to your account.
ATHJF reached its all-time high on Oct 29, 2021 with the price of 0.2973 USD, and its all-time low was 0.0030 USD and was reached on Jan 25, 2011. View more price dynamics on ATHJF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PERCHERON THERAPEUTICS LTD technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PERCHERON THERAPEUTICS LTD stock shows the strong sell signal. See more of PERCHERON THERAPEUTICS LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on PERCHERON THERAPEUTICS LTD future price: according to them, ATHJF price has a max estimate of 0.18 USD and a min estimate of 0.15 USD. Watch ATHJF chart and read a more detailed PERCHERON THERAPEUTICS LTD stock forecast: see what analysts think of PERCHERON THERAPEUTICS LTD and suggest that you do with its stocks.